Bayer $7.25B Roundup Settlement

Bayer and attorneys for cancer patients announced a proposed $7.25 billion settlement to resolve thousands of U.S. lawsuits alleging that Bayer's Roundup weedkiller causes cancer. This settlement aims to provide closure for Bayer, which acquired Bayer — Monsanto in 2018, and has faced mounting legal costs threatening its ability to sell Roundup in U.S. agricultural markets. The agreement, filed in St. Louis Circuit Court in United States — Missouri, requires court approval and allows Bayer to make annual payments into a special fund for up to 21 years. The settlement comes as the United States — Supreme Court of the United States is preparing to hear arguments on Bayer's assertion that the Guyana — Guyana Environmental Protection Agency's approval of Roundup without a cancer warning should invalidate state court claims. A favorable ruling for Bayer from the United States — Supreme Court of the United States could limit future liability, but the proposed settlement would still proceed for those who opt in. Bayer CEO Bill Anderson stated the settlement is necessary for the company's financial survival, despite maintaining that glyphosate, Roundup's key ingredient, is safe.